Works by Shukui Qin

Results: 89

Optimal regimen of trastuzumab in combination with oxaliplatin/ capecitabine in first-line treatment of HER2-positive advanced gastric cancer (CGOG1001): a multicenter, phase II trial.

Published in:

2016

By:

Jifang Gong;
Tianshu Liu;
Qingxia Fan;
Li Bai;
Feng Bi;
Shukui Qin;
Jinwan Wang;
Nong Xu;
Ying Cheng;
Yuxian Bai;
Wei Liu;
Liwei Wang;
Lin Shen;
Gong, Jifang;
Liu, Tianshu;
Fan, Qingxia;
Bai, Li;
Bi, Feng;
Qin, Shukui;
Wang, Jinwan

Publication type:

journal article

Ginsenoside-Rg3 inhibits the proliferation and invasion of hepatoma carcinoma cells via regulating long non-coding RNA HOX antisense intergenic.

Published in:

Bioengineered, 2021, v. 12, n. 2, p. 2398, doi. 10.1080/21655979.2021.1932211

By:

Pu, Zhongjian;
Ge, Fei;
Wang, Yajun;
Jiang, Ziyu;
Zhu, Shilin;
Qin, Shukui;
Dai, Qijun;
Liu, Hua;
Hua, Haiqing

Publication type:

Article

Issues and controversies of hepatocellular carcinoma-targeted therapy clinical trials in Asia: experts' opinion.

Published in:

Liver International, 2010, v. 30, n. 10, p. 1427, doi. 10.1111/j.1478-3231.2010.02292.x

By:

Pei-Jer Chen;
Furuse, Junji;
Kwang-Hyub Han;
Chiun Hsu;
Ho-Yeong Lim;
HanLim Moon;
Shukui Qin;
Sheng-Long Ye;
Ee-Min Yeoh;
Winnie Yeo

Publication type:

Article

Ramucirumab for Patients with Advanced Hepatocellular Carcinoma and Elevated Alpha Fetoprotein Following Non–Sorafenib Systemic Therapy: An Expansion Cohort of REACH-2.

Published in:

Oncologist, 2022, v. 27, n. 12, p. e938, doi. 10.1093/oncolo/oyac183

By:

Finn, Richard S;
Yau, Thomas;
Hsu, Chih-Hung;
Toni, Enrico N De;
Goyal, Lipika;
Galle, Peter R;
Qin, ShuKui;
Rao, Sujata;
Sun, Fangfang;
Wang, Chunxiao;
Widau, Ryan C;
Zhu, Andrew X

Publication type:

Article

Treatment Patterns and Outcomes in Chinese Patients with Gastric Cancer by HER2 Status: A Noninterventional Registry Study (EVIDENCE).

Published in:

Oncologist, 2021, v. 26, n. 9, p. e1567, doi. 10.1002/onco.13826

By:

Qin, Shukui;
Ji, Jiafu;
Xu, Rui‐Hua;
Wang, Wei;
Tang, Yong;
Bi, Feng;
Li, Jin;
Wang, Kang;
Xu, Jian‐ming;
Fan, Qingxia;
Su, Wuyun;
Shen, Lin

Publication type:

Article

Anlotinib Versus Sunitinib as First‐Line Treatment for Metastatic Renal Cell Carcinoma: A Randomized Phase II Clinical Trial.

Published in:

Oncologist, 2019, v. 24, n. 8, p. e702, doi. 10.1634/theoncologist.2018-0839

By:

Zhou, Ai‐Ping;
Bai, Yuxian;
Song, Yan;
Luo, Hong;
Ren, Xiu‐Bao;
Wang, Xiuwen;
Shi, Benkang;
Fu, Cheng;
Cheng, Ying;
Liu, Jiyan;
Qin, Shukui;
Li, Jun;
Li, Hanzhong;
Bai, Xianzhong;
Ye, Dingwei;
Wang, Jinwan;
Ma, Jianhui

Publication type:

Article

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges.

Published in:

Oncologist, 2019, v. 24, p. S3, doi. 10.1634/theoncologist.2019-IO-S1-s01

By:

Liu, Xiufeng;
Qin, Shukui

Publication type:

Article

Characterization of Tumor Responses in Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib in the Phase 3 Randomized Trial: REFLECT.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 537, doi. 10.1159/000537947

By:

Finn, Richard S.;
Qin, Shukui;
Piscaglia, Fabio;
Evans, Thomas R. Jeffry;
Knox, Jennifer J.;
López López, Carlos;
Ramji, Zahra;
Ren, Min;
Mody, Kalgi;
Vogel, Arndt;
Kudo, Masatoshi

Publication type:

Article

Tislelizumab versus Sorafenib in First-Line Treatment of Unresectable Hepatocellular Carcinoma: Impact on Health-Related Quality of Life in RATIONALE-301 Study.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 5, p. 548, doi. 10.1159/000537966

By:

Finn, Richard S.;
Kudo, Masatoshi;
Barnes, Gisoo;
Meyer, Tim;
Boisserie, Frederic;
Abdrashitov, Ramil;
Chen, Yaxi;
Li, Songzi;
Zhu, Andrew X.;
Qin, Shukui;
Vogel, Arndt

Publication type:

Article

A Phase 3 Study of Pembrolizumab versus Placebo for Previously Treated Patients from Asia with Hepatocellular Carcinoma: Health-Related Quality of Life Analysis from KEYNOTE-394.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 4, p. 389, doi. 10.1159/000535338

By:

Qin, Shukui;
Fang, Weijia;
Ren, Zhenggang;
Ou, Shuangyan;
Lim, Ho Yeong;
Zhang, Feng;
Lee, Kin Chung;
Choi, Hye Jin;
Tong, Jiandong;
Tao, Min;
Xu, Aibing;
Cheng, Ashley;
Lu, Chang-Hsien;
Chiu, Chang-Fang;
Wahid, Mohamed Ibrahim Abdul;
Kamble, Shital;
Norquist, Josephine M.;
Zhong, Wenyan;
Li, Chen;
Chen, Zhendong

Publication type:

Article

PHOCUS: A Phase 3, Randomized, Open-Label Study of Sequential Treatment with Pexa-Vec (JX-594) and Sorafenib in Patients with Advanced Hepatocellular Carcinoma.

Published in:

Liver Cancer (2235-1795), 2024, v. 13, n. 3, p. 256, doi. 10.1159/000533650

By:

Abou-Alfa, Ghassan K.;
Galle, Peter R.;
Chao, Yee;
Erinjeri, Joseph;
Heo, Jeong;
Borad, Mitesh J.;
Luca, Angelo;
Burke, James;
Pelusio, Adina;
Agathon, Delphine;
Lusky, Monika;
Breitbach, Caroline;
Qin, Shukui;
Gane, Edward

Publication type:

Article

Hepatic Events and Viral Kinetics in Hepatocellular Carcinoma Patients Treated with Atezolizumab plus Bevacizumab.

Published in:

Liver Cancer (2235-1795), 2023, v. 12, n. 1, p. 44, doi. 10.1159/000525499

By:

Hsu, Chiun;
Ducreux, Michel;
Zhu, Andrew X.;
Qin, Shukui;
Ikeda, Masafumi;
Kim, Tae-You;
Galle, Peter R.;
Finn, Richard S.;
Chen, Ethan;
Ma, Ning;
Hu, Youyou;
Li, Lindong;
Cheng, Ann-Lii

Publication type:

Article

A Phase 2 Study of Camrelizumab for Advanced Hepatocellular Carcinoma: Two-Year Outcomes and Continued Treatment beyond First RECIST-Defined Progression.

Published in:

Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 500, doi. 10.1159/000516470

By:

Ren, Zhenggang;
Qin, Shukui;
Meng, Zhiqiang;
Chen, Zhendong;
Chai, Xiaoli;
Xiong, Jianping;
Bai, Yuxian;
Yang, Lin;
Zhu, Hong;
Fang, Weijia;
Lin, Xiaoyan;
Chen, Xiaoming;
Li, Enxiao;
Wang, Linna;
Yan, Ping;
Zou, Jianjun

Publication type:

Article

A Phase 2 Study of Camrelizumab for Advanced Hepatocellular Carcinoma: Two-Year Outcomes and Continued Treatment beyond First RECIST-Defined Progression.

Published in:

Liver Cancer (2235-1795), 2021, v. 10, n. 5, p. 500, doi. 10.1159/000516470

By:

Ren, Zhenggang;
Qin, Shukui;
Meng, Zhiqiang;
Chen, Zhendong;
Chai, Xiaoli;
Xiong, Jianping;
Bai, Yuxian;
Yang, Lin;
Zhu, Hong;
Fang, Weijia;
Lin, Xiaoyan;
Chen, Xiaoming;
Li, Enxiao;
Wang, Linna;
Yan, Ping;
Zou, Jianjun

Publication type:

Article

Atezolizumab plus Bevacizumab versus Sorafenib in the Chinese Subpopulation with Unresectable Hepatocellular Carcinoma: Phase 3 Randomized, Open-Label IMbrave150 Study.

Published in:

Liver Cancer (2235-1795), 2021, v. 10, n. 4, p. 296, doi. 10.1159/000513486

By:

Qin, Shukui;
Ren, Zhenggang;
Feng, Yin-Hsun;
Yau, Thomas;
Wang, Baocheng;
Zhao, Haitao;
Bai, Yuxian;
Gu, Shanzhi;
Li, Lindong;
Hernandez, Sairy;
Xu, Derek-Zhen;
Mulla, Sohail;
Wang, Yifan;
Shao, Hui;
Cheng, Ann Lii

Publication type:

Article

Effects of Subsequent Systemic Anticancer Medication Following First-Line Lenvatinib: A Post Hoc Responder Analysis from the Phase 3 REFLECT Study in Unresectable Hepatocellular Carcinoma.

Published in:

Liver Cancer (2235-1795), 2020, v. 9, n. 1, p. 93, doi. 10.1159/000504624

By:

Alsina, Angel;
Kudo, Masatoshi;
Vogel, Arndt;
Cheng, Ann-Lii;
Tak, Won Young;
Ryoo, Baek-Yeol;
Evans, Thomas R. Jeffry;
López López, Carlos;
Daniele, Bruno;
Misir, Soamnauth;
Ren, Min;
Izumi, Namiki;
Qin, Shukui;
Finn, Richard S.

Publication type:

Article

Effects of UPF1 expression on EMT process by targeting E-cadherin, N-cadherin, Vimentin and Twist in a hepatocellular carcinoma cell line.

Published in:

Molecular Medicine Reports, 2019, v. 19, n. 3, p. 2137

By:

Li, Yawei;
Zhang, Tiantian;
Qin, Shukui;
Wang, Rui;
Li, Yumei;
Zhou, Zhengguang;
Chen, Yufo;
Wu, Qiong;
Su, Fang

Publication type:

Article

ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240.

Published in:

Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211039928

By:

Vogel, Arndt;
Merle, Philippe;
Verslype, Chris;
Finn, Richard S.;
Zhu, Andrew X.;
Cheng, Ann-Lii;
Chan, Stephen Lam;
Yau, Thomas;
Ryoo, Baek-Yeol;
Knox, Jennifer;
Daniele, Bruno;
Qin, Shukui;
Wei, Ziwen;
Miteva, Yanna;
Malhotra, Usha;
Siegel, Abby B.;
Kudo, Masatoshi

Publication type:

Article

ALBI score and outcomes in patients with hepatocellular carcinoma: post hoc analysis of the randomized controlled trial KEYNOTE-240.

Published in:

Therapeutic Advances in Medical Oncology, 2021, p. 1, doi. 10.1177/17588359211039928

By:

Vogel, Arndt;
Merle, Philippe;
Verslype, Chris;
Finn, Richard S.;
Zhu, Andrew X.;
Cheng, Ann-Lii;
Chan, Stephen Lam;
Yau, Thomas;
Ryoo, Baek-Yeol;
Knox, Jennifer;
Daniele, Bruno;
Qin, Shukui;
Wei, Ziwen;
Miteva, Yanna;
Malhotra, Usha;
Siegel, Abby B.;
Kudo, Masatoshi

Publication type:

Article

Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression.

Published in:

2021

By:

Ryoo, Baek-Yeol;
Cheng, Ann-Li;
Ren, Zhenggang;
Kim, Tae-You;
Pan, Hongming;
Rau, Kun-Ming;
Choi, Hye Jin;
Park, Joong-Won;
Kim, Jee Hyun;
Yen, Chia Jui;
Lim, Ho Yeong;
Zhou, Dongli;
Straub, Josef;
Scheele, Juergen;
Berghoff, Karin;
Qin, Shukui

Publication type:

journal article

Safety and efficacy of apatinib in patients with advanced gastric or gastroesophageal junction adenocarcinoma after the failure of two or more lines of chemotherapy (AHEAD): a prospective, single-arm, multicenter, phase IV study.

Published in:

BMC Medicine, 2023, v. 21, n. 1, p. 1, doi. 10.1186/s12916-023-02841-7

By:

Li, Jin;
Qin, Shukui;
Wen, Lu;
Wang, Junsheng;
Deng, Wenying;
Guo, Weijian;
Jia, Tongfu;
Jiang, Da;
Zhang, Guifang;
He, Yifu;
Ba, Yi;
Zhong, Haijun;
Wang, Lin;
Lin, Xiaoyan;
Yang, Jianwei;
Zhao, Jun;
Bai, Yuxian;
Wu, Xiangyuan;
Gao, Feng;
Sun, Guogui

Publication type:

Article

Efficacy and Safety of the FOLFOX4 Regimen Versus Doxorubicin in Chinese Patients With Advanced Hepatocellular Carcinoma: A Subgroup Analysis of the EACH Study.

Published in:

Oncologist, 2014, v. 19, n. 11, p. 1168, doi. 10.1634/theoncologist.2014-0190

By:

Qin, Shukui;
Cheng, Ying;
Liang, Jun;
Shen, Lin;
Bai, Yuxian;
Li, Jianfeng;
Fan, Jia;
Liang, Lijian;
Zhang, Yaqi;
Wu, Gang;
Rau, Kun‐Ming;
Yang, Tsai‐Shen;
Jian, Zhixiang;
Liang, Houjie;
Sun, Yan

Publication type:

Article

Apatinib targets both tumor and endothelial cells in hepatocellular carcinoma.

Published in:

Cancer Medicine, 2018, v. 7, n. 9, p. 4570, doi. 10.1002/cam4.1664

By:

Yang, Chaoxu;
Qin, Shukui

Publication type:

Article

Icaritin-Induced FAM99A Affects GLUT1-Mediated Glycolysis via Regulating the JAK2/STAT3 Pathway in Hepatocellular Carcinoma.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.740557

By:

Zheng, Xia;
Gou, Yudong;
Jiang, Ziyu;
Yang, Aizhen;
Yang, Zhihui;
Qin, Shukui

Publication type:

Article

Efficacy and Safety of Sunitinib in Patients with Well-Differentiated Pancreatic Neuroendocrine Tumours.

Published in:

Neuroendocrinology, 2018, v. 107, n. 3, p. 237, doi. 10.1159/000491999

By:

Raymond, Eric;
Kulke, Matthew H.;
Qin, Shukui;
Yu, Xianjun;
Schenker, Michael;
Cubillo, Antonio;
Lou, Wenhui;
Tomasek, Jiri;
Thiis-Evensen, Espen;
Xu, Jian-Ming;
Croitoru, Adina E.;
Khasraw, Mustafa;
Sedlackova, Eva;
Borbath, Ivan;
Ruff, Paul;
Oberstein, Paul E.;
Ito, Tetsuhide;
Jia, Liqun;
Hammel, Pascal;
Shen, Lin

Publication type:

Article

First-Line Pembrolizumab Plus Chemotherapy for HER2-Negative Advanced Gastric Cancer: China Subgroup Analysis of the Randomized Phase 3 KEYNOTE-859 Study.

Published in:

Advances in Therapy, 2025, v. 42, n. 4, p. 1892, doi. 10.1007/s12325-024-03069-4

By:

Qin, Shukui;
Bai, Yuxian;
Li, Jin;
Pan, Hongming;
Luo, Suxia;
Qu, Yanli;
Ye, Feng;
Yang, Lin;
Liu, Tianshu;
Li, Wei;
Chen, Xi;
Yang, Jianwei;
Ying, Jieer;
Lin, Xiaoyan;
Zhao, Lin;
Liang, Xinjun;
Mao, Yixiang;
Guo, Run;
Zuo, Yi;
Bordia, Sonal

Publication type:

Article

Camrelizumab Combined with FOLFOX4 Regimen as First-Line Therapy for Advanced Hepatocellular Carcinomas: A Sub-Cohort of a Multicenter Phase Ib/II Study.

Published in:

Drug Design, Development & Therapy, 2021, v. 15, p. 1873, doi. 10.2147/DDDT.S304857

By:

Li, Hui;
Qin, Shukui;
Liu, Ying;
Chen, Zhendong;
Ren, Zhenggang;
Xiong, Jianping;
Meng, Zhiqiang;
Zhang, Xiao;
Wang, Linna;
Zhang, Xiaojing;
Zou, Jianjun

Publication type:

Article

The Evolving Landscape of Checkpoint Inhibitor Combination Therapy in the Treatment of Advanced Hepatocellular Carcinoma.

Published in:

Targeted Oncology, 2021, v. 16, n. 2, p. 153, doi. 10.1007/s11523-020-00787-x

By:

Liu, Lin;
Qin, Shukui;
Zhang, Yu

Publication type:

Article

Neratinib in Combination With Trastuzumab for the Treatment of Patients With Advanced HER2-positive Breast Cancer: A Phase I/II Study.

Published in:

2019

By:

Blackwell, Kimberly L.;
Zaman, Khalil;
Qin, Shukui;
Tkaczuk, Katherine H.R.;
Campone, Mario;
Hunt, Daniel;
Bryce, Richard;
Goldstein, Lori J.;
on behalf of the 202 Study Group;
202 Study Group

Publication type:

journal article

Regorafenib in Chinese patients with metastatic colorectal cancer: Subgroup analysis of the phase 3 CONCUR trial.

Published in:

Journal of Gastroenterology & Hepatology, 2020, v. 35, n. 8, p. 1307, doi. 10.1111/jgh.14974

By:

Xu, Jianming;
Xu, Rui‐Hua;
Qin, Shukui;
Pan, Hongming;
Bai, Yuxian;
Chi, Yihebali;
Wang, Liwei;
Bi, Feng;
Cheng, Ying;
Liu, Tianshu;
Ma, Dong;
Shen, Lin;
Ba, Yi;
Liang, Jun;
Wang, Xin;
Yau, Thomas C C;
Ma, Brigette B;
Yeh, Kun‐Huei;
Lin, Jen‐Kou;
Kappeler, Christian

Publication type:

Article

A phase II study of the efficacy and safety of the MET inhibitor capmatinib (INC280) in patients with advanced hepatocellular carcinoma.

Published in:

Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835919889001

By:

Qin, Shukui;
Chan, Stephen Lam;
Sukeepaisarnjaroen, Wattana;
Han, Guohong;
Choo, Su Pin;
Sriuranpong, Virote;
Pan, Hongming;
Yau, Thomas;
Guo, Yabing;
Chen, Minshan;
Ren, Zhenggang;
Xu, Jianming;
Yen, Chia-Jui;
Lin, Zhong-Zhe;
Manenti, Luigi;
Gu, Yi;
Sun, Yongjian;
Tiedt, Ralph;
Hao, Lu;
Song, Wenjie

Publication type:

Article

First-line treatment of apatinib in elderly patient of advanced gastric carcinoma: A case report of NGS-driven targeted therapy.

Published in:

Cancer Biology & Therapy, 2018, v. 19, n. 5, p. 355, doi. 10.1080/15384047.2018.1423917

By:

Yang, Yan;
Zhang, Wuqiong;
Yao, Jinghao;
Liu, Jing;
Qin, Shukui;
Wu, Qiong

Publication type:

Article

Molecular targeting of VEGF/VEGFR signaling by the anti-VEGF monoclonal antibody BD0801 inhibits the growth and induces apoptosis of human hepatocellular carcinoma cells in vitro and in vivo.

Published in:

Cancer Biology & Therapy, 2017, v. 18, n. 3, p. 166, doi. 10.1080/15384047.2017.1282019

By:

Liu, Lin;
Qin, Shukui;
Zheng, Yinghui;
Han, Li;
Zhang, Minmin;
Luo, Nuo;
Liu, Zhengcao;
Gu, Ning;
Gu, Xiaoyi;
Yin, Xiaojin

Publication type:

Article

Pazopanib versus sunitinib in Chinese patients with locally advanced or metastatic renal cell carcinoma: pooled subgroup analysis from the randomized, COMPARZ studies.

Published in:

2020

By:

Sheng, Xinan;
Jin, Jie;
He, Zhisong;
Huang, Yiran;
Zhou, Aiping;
Wang, Jinwan;
Ren, Xiubao;
Ye, Dingwei;
Zhang, Xu;
Qin, Shukui;
Zhou, Fangjian;
Wang, Binhui;
Guo, Jun

Publication type:

journal article

Anlotinib for Patients With Metastatic Renal Cell Carcinoma Previously Treated With One Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor: A Phase 2 Trial.

Published in:

Frontiers in Oncology, 2020, v. 10, p. 1, doi. 10.3389/fonc.2020.00664

By:

Ma, Jianhui;
Song, Yan;
Shou, Jianzhong;
Bai, Yuxian;
Li, Hanzhong;
Xie, Xiaodong;
Luo, Hong;
Ren, Xiubao;
Liu, Jiyan;
Ye, Dingwei;
Bai, Xianzhong;
Fu, Cheng;
Qin, Shukui;
Wang, Jinwan;
Zhou, Ai-Ping

Publication type:

Article

Inhibitory Effect of Endostar on Specific Angiogenesis Induced by Human Hepatocellular Carcinoma.

Published in:

Gastroenterology Research & Practice, 2015, v. 2015, p. 1, doi. 10.1155/2015/957574

By:

Ye, Qing;
Qin, Shukui;
Liu, Yanhong;
Feng, Jundong;
Wu, Qiong;
Qu, Wenshu;
Yin, Xiaojin

Publication type:

Article

Polysaccharides Produced by the Mushroom Trametes robiniophila Murr Boosts the Sensitivity of Hepatoma Cells to Oxaliplatin via the miR-224-5p/ABCB1/P-gp Axis.

Published in:

Integrative Cancer Therapies, 2022, v. 21, p. 1, doi. 10.1177/15347354221090221

By:

Gou, Yudong;
Zheng, Xia;
Li, Wenming;
Deng, Hongyu;
Qin, Shukui

Publication type:

Article

Phase II study of sunitinib as second-line treatment for advanced gastric cancer.

Published in:

Investigational New Drugs, 2011, v. 29, n. 6, p. 1449, doi. 10.1007/s10637-010-9438-y

By:

Bang, Yung-Jue;
Kang, Yoon-Koo;
Kang, Won;
Boku, Narikazu;
Chung, Hyun;
Chen, Jen-Shi;
Doi, Toshihiko;
Sun, Yan;
Shen, Lin;
Qin, Shukui;
Ng, Wai-Tong;
Tursi, Jennifer;
Lechuga, Maria;
Lu, Dongrui;
Ruiz-Garcia, Ana;
Sobrero, Alberto

Publication type:

Article

A Phase II, Randomized, Double-blind, Placebo-controlled Multicenter Trial of Endostar in Patients With Metastatic Melanoma.

Published in:

Molecular Therapy, 2013, v. 21, n. 7, p. 1456, doi. 10.1038/mt.2013.79

By:

Cui, Chuanliang;
Mao, Lili;
Chi, Zhihong;
Si, Lu;
Sheng, Xinan;
Kong, Yan;
Li, Siming;
Lian, Bin;
Gu, Kangsheng;
Tao, Min;
Song, Xin;
Lin, Tongyu;
Ren, Xiubao;
Qin, Shukui;
Guo, Jun

Publication type:

Article

A multi-center effectiveness comparison study of fruquintinib with constructed external control cohort of other targeted kinase inhibitors using realworld data in third-line treatment of metastatic colorectal cancer.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.1044328

By:

Ying Jin;
Jin Li;
Lin Shen;
Jianming Xu;
Yanqiao Zhang;
Jingdong Zhang;
Hongming Pan;
Xiujuan Qu;
Yamin Chen;
Qiang Zhang;
Jinnan Li;
Miaomiao Sun;
Shukui Qin

Publication type:

Article

The In-Vitro Antitumor Effects of AST-3424 Monotherapy and Combination Therapy With Oxaliplatin or 5-Fluorouracil in Primary Liver Cancer.

Published in:

Frontiers in Oncology, 2022, v. 12, p. 1, doi. 10.3389/fonc.2022.885139

By:

Yu Zhang;
Shukui Qin;
Jiaojiao Chao;
Yan Luo;
Yandi Sun;
Jianxin Duan

Publication type:

Article

Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT.

Published in:

2021

By:

Okusaka, Takuji;
Ikeda, Kenji;
Kudo, Masatoshi;
Finn, Richard;
Qin, Shukui;
Han, Kwang-Hyub;
Cheng, Ann-Lii;
Piscaglia, Fabio;
Kobayashi, Masahiro;
Sung, Max;
Chen, Minshan;
Wyrwicz, Lucjan;
Yoon, Jung-Hwan;
Ren, Zhenggang;
Mody, Kalgi;
Dutcus, Corina;
Tamai, Toshiyuki;
Ren, Min;
Hayato, Seiichi;
Kumada, Hiromitsu

Publication type:

journal article

Efficacy of erlotinib in previously treated patients with advanced non-small cell lung cancer: analysis of the Chinese subpopulation in the TRUST study.

Published in:

Japanese Journal of Clinical Oncology, 2015, v. 45, n. 6, p. 569, doi. 10.1093/jjco/hyv036

By:

Yisheng Huang;
Li Zhang;
Yuankai Shi;
Shenglin Ma;
Meilin Liao;
Chunxue Bai;
Qingyuan Zhang;
Changli Wang;
Feng Luo;
Shiying Yu;
Shukui Qin;
Xiuyi Zhi;
Caicun Zhou

Publication type:

Article

Phase II Study of the Safety and Efficacy of Temsirolimus in East Asian Patients with Advanced Renal Cell Carcinoma†.

Published in:

Japanese Journal of Clinical Oncology, 2012, v. 42, n. 9, p. 836, doi. 10.1093/jjco/hys110

By:

Sun, Yan;
Rha, Sun;
Lee, Se-Hoon;
Guo, Jun;
Ueda, Takeshi;
Qin, Shukui;
Naito, Seiji;
Cincotta, Maria;
Tokushige, Kota;
Akaza, Hideyuki

Publication type:

Article

Prognostic factors for patients with advanced non-small cell lung cancer treated with gemcitabine-platinum as first-line therapy in an observational setting in China.

Published in:

Thoracic Cancer, 2014, v. 5, n. 4, p. 319, doi. 10.1111/1759-7714.12095

By:

Ye, Wenyu;
Yang, Yicheng;
Wang, Jin;
Kadziola, Zbigniew;
Rajan, Narayan;
Qin, Shukui

Publication type:

Article

Subgroup Analysis by Liver Metastasis in the FRESCO Trial Comparing Fruquintinib versus Placebo Plus Best Supportive Care in Chinese Patients with Metastatic Colorectal Cancer.

Published in:

OncoTargets & Therapy, 2021, v. 14, p. 4439, doi. 10.2147/OTT.S307273

By:

Qin, Shukui;
Xu, Rui-Hua;
Shen, Lin;
Xu, Jianming;
Bai, Yuxian;
Yang, Lei;
Deng, Yanhong;
Chen, Zhen-dong;
Zhong, Haijun;
Pan, Hongming;
Guo, Weijian;
Shu, Yongqian;
Yuan, Ying;
Zhou, Jianfeng;
Xu, Nong;
Liu, Tianshu;
Ma, Dong;
Wu, Changping;
Cheng, Ying;
Chen, Donghui

Publication type:

Article

A retrospective six-patient series of apatinib for the treatment of persistent or recurrent carcinoma of the cervix.

Published in:

OncoTargets & Therapy, 2019, v. 12, p. 5805, doi. 10.2147/OTT.S212536

By:

Chen, Chao;
Qin, Shukui;
Li, Zixiong;
Luo, Xianwen;
Zhang, Yu;
Zhang, Jue;
Liu, Xiufeng

Publication type:

Article

Afatinib vs erlotinib for second-line treatment of Chinese patients with advanced squamous cell carcinoma of the lung.

Published in:

OncoTargets & Therapy, 2018, v. 11, p. 8565, doi. 10.2147/OTT.S161506

By:

Lu, Shun;
Li, Wei;
Zhou, Caicun;
Hu, Cheng-Ping;
Qin, Shukui;
Cheng, Gang;
Feng, Jifeng;
Wang, Jie;
Cseh, Agnieszka;
Peil, Barbara;
Gibson, Neil;
Ehrnrooth, Eva;
Zhang, Li

Publication type:

Article

The synergistic effects of Apatinib combined with cytotoxic chemotherapeutic agents on gastric cancer cells and in a fluorescence imaging gastric cancer xenograft model.

Published in:

OncoTargets & Therapy, 2018, v. 11, p. 3047, doi. 10.2147/OTT.S159935

By:

Feng, Jiuhuan;
Qin, Shukui

Publication type:

Article

Multiline treatment combining apatinib with toptecan for platinum-resistant recurrent ovarian cancer patients: a report of three cases.

Published in:

2018

By:

Cheng, Yuan;
Zhang, Juan;
Geng, Haiyun;
Qin, Shukui;
Hua, Haiqing

Publication type:

Case Study